133 related articles for article (PubMed ID: 6025965)
1. [Therapeutic results in the treatment of primary and secondary hemochromatoses with Desferal].
Wöhler F
Blut; 1967 Apr; 15(1):33-42. PubMed ID: 6025965
[No Abstract] [Full Text] [Related]
2. Desferal therapy in iron storage disease.
Thompson RB; Owen DM; Bell WN
Am J Med Sci; 1967 Apr; 253(4):453-60. PubMed ID: 6021380
[No Abstract] [Full Text] [Related]
3. Evaluation of continuous desferrioxamine administration in adults with transfusional hemosiderosis.
Cooper B; Bunn HF; Propper RD; Nathan DG; Rosenthal DS; Moloney WC
Trans Assoc Am Physicians; 1977; 90():335-41. PubMed ID: 611665
[No Abstract] [Full Text] [Related]
4. Advances in the use of iron-chelating agents for the treatment of iron overload.
Modell B
Prog Hematol; 1979; 11():267-312. PubMed ID: 392593
[No Abstract] [Full Text] [Related]
5. [Use of desferal in treatment of sideroses of different origin. (Literature review)].
Turbina NS
Probl Gematol Pereliv Krovi; 1968 Jul; 13(7):47-52. PubMed ID: 4898933
[No Abstract] [Full Text] [Related]
6. Iron loading and thalassemia--experimental successes and practical realities.
Weatherall DJ; Pippard MJ; Callender ST
N Engl J Med; 1977 Aug; 297(8):445-6. PubMed ID: 560628
[No Abstract] [Full Text] [Related]
7. [Further experiences with iron-chelating therapy (desferrioxamine and ascorbic acid) in siderochromatosis and Cooley's disease].
Cartei G; Cazzavillan M; Chisesi T; Battista R; Barbui T; Dini E
Minerva Med; 1978 Mar; 69(13):811-21. PubMed ID: 643223
[No Abstract] [Full Text] [Related]
8. [Specific treatment of excessive iron deposition in the tissues].
Plachecka-Gutowska M; Mikolajew M
Pol Arch Med Wewn; 1965; 35(1):111-7. PubMed ID: 5900073
[No Abstract] [Full Text] [Related]
9. [Contribution to the problem of hemochromatosis].
Bruns W; Michaelis D; Takác A; Langsch HG
Dtsch Z Verdau Stoffwechselkr; 1966 Feb; 25(6):363-70. PubMed ID: 5998360
[No Abstract] [Full Text] [Related]
10. THE TREATMENT OF HAEMOCHROMATOSIS WITH DESFERRIOXAMINE.
WOEHLER F
Acta Haematol; 1963 Aug; 30():65-87. PubMed ID: 14064792
[No Abstract] [Full Text] [Related]
11. Cooley anemia: high transfusion regimen and chelation therapy, results, and perspective.
Weiner M; Karpatkin M; Hart D; Seaman C; Vora SK; Henry WL; Piomelli S
J Pediatr; 1978 Apr; 92(4):653-8. PubMed ID: 633033
[No Abstract] [Full Text] [Related]
12. The treatment of hemosiderosis in thalassaemia major with desferrioxamine-B.
Kirimlidis S; Philippidis P; Drossos C; Economidis J
Helv Paediatr Acta; 1966 Sep; 21(4):343-50. PubMed ID: 5997620
[No Abstract] [Full Text] [Related]
13. Long-term administration of desferrioxamine in thalassaemia major.
Seshadri R; Colebatch JH; Gordon P; Ekert H
Arch Dis Child; 1974 Aug; 49(8):621-6. PubMed ID: 4278421
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of iron storage disease with desferrioxamine (Desferal test).
Wöhler F
Acta Haematol; 1964 Dec; 32(6):321-37. PubMed ID: 5005470
[No Abstract] [Full Text] [Related]
15. Iron chelating therapy in thalassemia: current problems.
Russo G
Haematologica; 1990; 75 Suppl 5():84-8. PubMed ID: 2086385
[No Abstract] [Full Text] [Related]
16. [Evaluation of iron balance in homozygous beta-thalassemia subjects treated with desferrioxamine administered subcutaneously].
Ferrara M; Galdo Capotorti M; Ponte G; Esposito L
Pediatria (Napoli); 1983; 91(4):371-7. PubMed ID: 6545400
[No Abstract] [Full Text] [Related]
17. [Continuous subcutaneous desferrioxamine injection in primary idiopathic hemochromatosis with macrocytic anemia].
Schneider C; Richter H; Fischer JL; Larcher W
Internist (Berl); 1989 May; 30(5):335-7. PubMed ID: 2661477
[No Abstract] [Full Text] [Related]
18. [Treatment of post-transfusion iron overload by deferoxamine].
de Montalembert M; Llados A; Hannedouche T; Girot R
Arch Fr Pediatr; 1989 Feb; 46(2):99-105. PubMed ID: 2735804
[TBL] [Abstract][Full Text] [Related]
19. Iron chelation therapy with deferoxamine in Cooley anemia.
Cohen A; Schwartz E
J Pediatr; 1978 Apr; 92(4):643-7. PubMed ID: 633031
[TBL] [Abstract][Full Text] [Related]
20. [Deferoxamine in hemosiderosis. Fecal iron excretion during continuous subcutaneous infusion].
Krüger N; Kijewski H; König R; Tillmann W; Schröter W
Dtsch Med Wochenschr; 1984 Nov; 109(44):1682-5. PubMed ID: 6489181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
